Chun-Feng Huang | Health Professions | Best Researcher Award

Posted on by ScienceFather

Assist. Prof. Dr. Chun-Feng Huang | Health Professions | Best Researcher Award

Chief of Family Medicine at En Chu Kong Hospital/National Yang Ming Chiao Tung University, Taiwan

Dr. Chun-Feng Huang is an Assistant Professor at the National Yang Ming Chiao Tung University and the Chief of Family Medicine at En Chu Kong Hospital. With a rich academic background, including a Ph.D. from Taipei Medical University and an MD from National Yang Ming Chiao Tung University, Dr. Huang is a certified expert in Family Medicine, Hospice and Palliative Medicine, and Osteoporosis. His research spans metabolomics, precision medicine, gerontology, and osteoporosis, with numerous publications in reputable journals. 🌊🔬.

Publication Profile

Education

Dr. Chun-Feng Huang earned his Doctor of Medicine degree from the National Yang Ming Chiao Tung University, School of Medicine, Taiwan. He further specialized by obtaining a Ph.D. from Taipei Medical University’s Graduate Institute of Clinical Medicine. Complementing his advanced education, Dr. Huang holds various board certifications: Family Medicine, Hospice and Palliative Medicine, Integrative Medicine, and Osteoporosis. Additionally, he is a Certified Clinical Densitometrist accredited by the International Society for Clinical Densitometry (ISCD). His academic journey reflects a deep commitment to continuous learning and specialization in both clinical and research domains, equipping him with a robust foundation to tackle complex medical challenges. Dr. Huang’s educational background not only highlights his expertise in medicine but also underscores his dedication to advancing patient care through education, research, and clinical excellence.

Experience

Dr. Chun-Feng Huang’s career is marked by influential roles in academia and clinical practice. He currently serves as an Assistant Professor at the National Yang Ming Chiao Tung University and Chief of the Department of Family Medicine at En Chu Kong Hospital. Previously, he directed the Department of Family Medicine at the same university hospital from 2016 to 2022. His leadership extended to chairing healthcare services for correctional institutions and community development associations. As Deputy Secretary General and former Prevention Committee Deputy Chairman of the Taiwan Association of Family Medicine, Dr. Huang has shaped national health policies. He also contributed as a Director for the Taipei Smart City IoT Association. His experience in reviewing medical policies for Taiwan’s FDA and involvement in mountain healthcare projects demonstrates his dedication to improving public health systems and addressing diverse healthcare needs through integrated solutions.

Awards and Honors

Dr. Chun-Feng Huang has received numerous accolades for his contributions to medicine and community health. He was recognized with the First Prize at the Annual Academic Conference by the Taiwan Association of Family Medicine in both 2011 and 2018. Between 2010 and 2017, he served as the Principal Investigator for key projects, including the Mountain and Offshore Healthcare Plan and healthcare services for correctional institutions. His leadership was also acknowledged as Chairman of the Yilan County Kang Tai Community Development Association and as Director of the Taipei Smart City IoT Association. His continuous service to healthcare is highlighted by his role as a reviewer for the Taiwan Food and Drug Administration. These awards and honors underscore his commitment to innovation, excellence in family medicine, and the advancement of public health initiatives.

Research Focus

Dr. Chun-Feng Huang’s research centers on metabolomics, precision medicine, gerontology, and osteoporosis. He explores the intricate connections between metabolic pathways and chronic diseases, aiming to develop personalized medical interventions. His work in precision medicine emphasizes tailoring treatments to individual genetic and environmental factors, particularly for elderly populations. In gerontology, he focuses on improving quality of life and functional health outcomes, with a special interest in sarcopenia and cognitive decline. Dr. Huang is also a leading expert in osteoporosis research, contributing to guidelines for fracture prevention and management. His studies include the effects of medications on bone health and the development of innovative treatments to reduce mortality in osteoporosis patients. Through multidisciplinary collaborations, he aims to bridge clinical research with practical healthcare solutions, advancing the understanding and management of age-related diseases.

Conclusion

Dr. Chun-Feng Huang is an outstanding candidate for the Best Researcher Award. His prolific research output, leadership roles, and clinical impact demonstrate excellence and dedication. Addressing the suggested areas for improvement could further elevate his contributions, but his current achievements already position him as a leading figure in his field.

Publication Top Notes

Nicotinuric acid: a potential marker of metabolic syndrome through a metabolomics-based approach

Authors: CF Huang, ML Cheng, CM Fan, CY Hong, MS Shiao

Citations: 57

Year: 2013

Effects of incorporating multidomain interventions into integrated primary care on quality of life: a randomised controlled trial

Authors: WJ Lee, LN Peng, CH Lin, RC Chen, SZ Lin, CH Loh, SL Kao, TS Hung, …

Citations: 55

Year: 2021

Heat stress responses modulate calcium regulations and electrophysiological characteristics in atrial myocytes

Authors: YC Chen, YH Kao, CF Huang, CC Cheng, YJ Chen, SA Chen

Citations: 38

Year: 2010

Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: 2022 update

Authors: TW Tai, CF Huang, HK Huang, RS Yang, JF Chen, TT Cheng, FP Chen, …

Citations: 29

Year: 2023

Treatment of osteoporosis after hip fracture is associated with lower all-cause mortality: a nationwide population study

Authors: TW Tai, CC Li, CF Huang, WP Chan, CH Wu

Citations: 24

Year: 2022

Mononucleated and binucleated cardiomyocytes in left atrium and pulmonary vein have different electrical activity and calcium dynamics

Authors: CF Huang, YC Chen, HI Yeh, SA Chen

Citations: 22

Year: 2012

Pharmacologic intervention for prevention of fractures in osteopenic and osteoporotic postmenopausal women: Systemic review and meta-analysis

Authors: CH Wu, WC Hung, L Chang, TT Tsai, YF Chang, EV McCloskey, NB Watts, …

Citations: 19

Year: 2020

Retrospective study of the effects of zoledronic acid on muscle mass in osteoporosis patients

Authors: CF Huang, MS Shiao, TY Mao

Citations: 17

Year: 2021

Detection of ventilatory thresholds using near-infrared spectroscopy with a polynomial regression model

Authors: CW Lin, CF Huang, JS Wang, LL Fu, TY Mao

Citations: 15

Year: 2020

First insights on value-based healthcare of elders using ICHOM older person standard set reporting

Behnaz Bagherian | Medical-surgical nursing | Best Researcher Award

Posted on by ScienceFather

Assist. Prof. Dr. Behnaz Bagherian | Medical-surgical nursing | Best Researcher Award

Assist. Prof. Dr. Behnaz Bagherian, Kerman University of Medical Sciences, Iran

Dr. Behnaz Bagherian, an Assistant Professor at the Razi School of Nursing and Midwifery, Kerman University of Medical Sciences (Iran), specializes in medical-surgical nursing, diabetes care, and technological innovations in nursing. She earned her Ph.D. in Nursing (2016) and holds a Geriatric Biology Fellowship (2020). With over two decades of experience in clinical and academic roles, she excels in intensive care, diabetes education, and advanced nursing practices. Dr. Bagherian’s research interests include AI in healthcare, qualitative methods, and caring in nursing. She is a prolific scholar with numerous publications and accolades for academic excellence. ✨📚

 

Publication Profile

Google Scholar

Educational Background

Dr. Behnaz Bagherian has a distinguished academic journey, beginning with a Bachelor of Nursing from the School of Nursing at Kerman University of Medical Sciences, Iran, in 1999. She earned her Master of Science in Nursing from the same institution in 2006. Driven by a passion for advancing nursing practice, Dr. Bagherian completed her Doctor of Philosophy in Nursing in 2016. To further specialize, she pursued a Geriatric Biology Fellowship at Kerman University of Medical Sciences in 2020. Her academic achievements highlight her commitment to nursing excellence and research. 👩‍⚕️📚

 

Work Experience

Dr. Behnaz Bagherian’s career spans over two decades in nursing and academia. She began as an intensive care nurse at a hospital affiliated with Kerman University of Medical Sciences from 1999 to 2007. From 2007 to 2013, she served as a diabetes educator and supervisor at an endocrine clinic. Her academic journey began with a collaboration at the Nursing and Midwifery School of Kerman University from 2014 to 2017. Since 2017, she has been an Assistant Professor at the Razi School of Nursing and Midwifery, Kerman University of Medical Sciences, shaping the future of nursing education. 📚✨

 

Teaching Experience

Dr. Behnaz Bagherian has extensive teaching experience in both theoretical and clinical nursing education. She specializes in various aspects of nursing, including methods of qualitative and quantitative research in nursing, medical-surgical nursing, and diabetes education. Additionally, she provides training on nursing care for patients with integumentary system disorders and burns. Dr. Bagherian also focuses on the fundamental concepts and skills in nursing, ensuring that students gain a strong foundation in the discipline. Her diverse teaching background reflects her commitment to advancing nursing education and practice. ✨🩺

 

Research Interests

Dr. Behnaz Bagherian’s research interests span both qualitative and quantitative nursing research methodologies, focusing on improving patient care and advancing the nursing profession. Her work in diabetes research seeks to enhance management strategies and patient outcomes. She is also dedicated to intensive care nursing research, exploring ways to optimize care in critical settings. Additionally, Dr. Bagherian investigates the role of caring in nursing, the integration of technological caring, and the potential of artificial intelligence in healthcare. Her research aims to innovate nursing practices and improve patient-centered care. 🤖❤️📊

 

Research Focus

Assist. Prof. Dr. Behnaz Bagherian’s research interests primarily revolve around nursing care and its intersection with technology. Her studies explore the impact of technological advancements on critical care and intensive care nursing. She investigates nursing ethics, including moral sensitivity and the quality of care, alongside exploring diabetes education and maternal health. Dr. Bagherian’s work also delves into spirituality in nursing and self-care for pediatric and neonatal patients. Additionally, she focuses on simulation-based training and nursing education, aiming to enhance professional skills and patient care. 💻👩‍⚕️💡

Publication Top Notes

  • Effects of technology on nursing care and caring attributes of a sample of Iranian critical care nurses – Intensive and Critical Care Nursing – Cited by 70 – Year 2017 📱💉
  • Missed nursing care and its related factors from the points of view of nurses affiliated to Kerman University of Medical Sciences in 2017 – BMC Nursing – Cited by 49 – Year 2019 ❌🩺
  • Simulation-based mastery improves nursing skills in BSc nursing students: a quasi-experimental study – BMC Nursing – Cited by 41 – Year 2021 🏫🩺
  • Meaning of caring from critical care nurses’ perspective: a phenomenological study – J Intensive Crit Care – Cited by 28 – Year 2017 💭❤️
  • Evaluation of moral sensitivity in nursing students of Bushehr University of Medical Sciences in 2016 – Iranian Journal of Medical Ethics and History of Medicine – Cited by 24 – Year 2018 ⚖️🧑‍⚖️
  • The relationship between clinical dishonesty and perceived clinical stress among nursing students in southeast of Iran – BMC Nursing – Cited by 23 – Year 2020 😷🧠
  • The effect of a training program on maternal role adaptation and self-esteem of mothers with preterm infants: a quasi-experimental study – BMC Women’s Health – Cited by 17 – Year 2021 👶👩‍🍼
  • Assessing virtual education on nurses’ perception and knowledge of developmental care of preterm infants: a quasi-experimental study – BMC Nursing – Cited by 15 – Year 2022 💻👶
  • Self-care status in children with congenital heart disease: A mixed-method study – Journal of Child and Adolescent Psychiatric Nursing – Cited by 15 – Year 2020 💓👶
  • Caring within a web of paradoxes: The critical care nurses’ experiences of beneficial and harmful effects of technology on nursing care – British Journal of Medicine and Medical Research – Cited by 15 – Year 2016 🔄💻

Serhat Aras | Health Professions | Best Researcher Award

Posted on by ScienceFather

Assoc. Prof. Dr. Serhat Aras | Health Professions | Best Researcher Award

Assoc. Prof. Dr. Serhat Aras, University of Health Sciences Turkey, Turkey

Assoc. Prof. Dr. Serhat Aras is a nuclear physicist with a Ph.D. from Manisa Celal Bayar University, where he focused on Monte Carlo methods in dose calculations for prostate brachytherapy. He currently serves at the University of Health Sciences, Istanbul, specializing in medical imaging and radiological sciences. Dr. Aras has led research on the radiobiological effects of advanced radiation techniques in cancer treatments, including studies on breast and lung cancer. His teaching includes courses on radiologic imaging, radiation safety, and nuclear medicine. In 2023, he received an International Research Award in India. 🧪📡👨‍🏫

 

Publication Profile

Google Scholar


Academic Background

Dr. Aras completed his PhD in Nuclear Physics at Celal Bayar University, focusing on advanced methodologies for calculating patient doses in prostate brachytherapy using Monte Carlo simulations. His Master’s research also focused on dose distribution in brachytherapy, providing a solid foundation for his contributions to medical physics. His specialized education enhances his capacity to innovate in patient-specific dosimetry, an essential area in clinical radiotherapy.

Professional Experience

Dr. Aras serves in the Medical Imaging Techniques Program at Istanbul Health Sciences University. His roles have included Assistant Professor and Lecturer, where he has imparted his knowledge in courses such as Radiologic Imaging Physics, Radiation Safety, and Nuclear Medicine. His expertise in radiology and medical physics makes him an asset to the field, both in research and education, as he prepares future professionals in these highly technical fields.

Research Projects

Dr. Aras has led numerous research projects in radiobiology and oncology, demonstrating his commitment to advancing medical science. His projects include the study of radiobiological impacts on non-small cell lung cancer xenografts and the protective effects of melatonin and probiotics against radiation-induced tissue damage in experimental rat models. His role as a principal investigator in these studies reflects his leadership and research aptitude, focusing on innovative approaches to radiotherapy and radiation protection.

Awards and Recognition

Dr. Aras received the 2023 International Research Award from ISSN, India, which highlights his global research impact. This accolade, along with his publication record, underscores his contributions to nuclear and medical physics on an international level.

Conclusion

Assoc. Prof. Dr. Serhat Aras’s extensive research in medical imaging, radiotherapy, and radiobiological protection, combined with his teaching and leadership roles, makes him a suitable and commendable candidate for the Best Researcher Award. His contributions to nuclear physics applications in medicine reflect both a commitment to scientific advancement and a positive impact on clinical practices.

 

Publication Top Notes  

  • Dosimetric comparison of three-dimensional conformal radiotherapy (3D-CRT) and intensity modulated radiotherapy techniques (IMRT) with radiotherapy dose simulations for left breast cancer 💉 – Cited by: 41, Year: 2019
  • Dosimetric comparison of superflab and specially prepared bolus materials used in radiotherapy practice 📏 – Cited by: 27, Year: 2020
  • The role of melatonin on acute thyroid damage induced by high dose rate X-ray in head and neck radiotherapy 🌙 – Cited by: 12, Year: 2021
  • Radioprotective effect of melatonin against radiotherapy-induced cerebral cortex and cerebellum damage in rat 🐭 – Cited by: 11, Year: 2020
  • Radiobiological comparison of flattening filter (FF) and flattening filter free (FFF) beam in rat laryngeal tissue 🔬 – Cited by: 8, Year: 2020
  • Home care for mastectomy patients 🏥 – Cited by: 0, Year: 2008
  • A survey study of radiation protection awareness among radiology technicians in Mogadishu, Somalia 🌍 – Cited by: 7, Year: 2020
  • Thoracic re-irradiation for locally recurrent lung cancer 🫁 – Cited by: 5, Year: 2016
  • The dosimetric comparison and evaluation of helical tomotherapy, volumetric-modulated arc radiotherapy (VMAT), step-and-shoot and sliding window radiotherapy techniques in breast cancer 💻 – Cited by: 4, Year: 2022
  • Effect of Flattening Filter and Flattening Filter Free beams on radiotherapy-induced peripheral blood cell damage ⚗️ – Cited by: 4, Year: 2021

 

 

 

 

 

Nilank Shah MD | Medicine | Best Researcher Award

Posted on by ScienceFather

Dr. Nilank Shah MD | Medicine | Best Researcher Award

Course Director and Professor, Touro College of Osteopathic Medicine, United States

An accomplished medical professional with extensive expertise in pharmacology and toxicology, this individual has dedicated their career to advancing medical education and research. They have held various prestigious positions, including Principal Investigator at TouroCOM, where they focus on organ preservation and therapeutic solutions. Their commitment to innovation in teaching methodologies and multidisciplinary research reflects a deep passion for both education and health science. 🌟

Publication Profile

Google Scholar

Education

Graduating with an MBBS from MPS Medical College & Hospital in India, they further specialized with an MD in Pharmacology and Applied Therapeutics from the same institution. Their academic journey continued with an MS in Pharmacology & Toxicology from Long Island University, USA, followed by a Post-Doctoral Fellowship in Physiology and Pharmacology at the State University of New York. Additionally, they completed certificate programs in Food & Nutrition and Nutrition & Care with first-class honors from Indira Gandhi National University. 🎓

Experience

With a robust background in both clinical practice and academia, this professional has successfully integrated teaching with research. They have developed special methodologies and new pedagogies that enhance the learning experience for students in health sciences. Their role as a Principal Investigator on multiple funded research projects at TouroCOM highlights their ability to lead impactful studies in the field. 💼

Research Focus

Their research primarily concentrates on organ preservation solutions and the therapeutic effectiveness of innovative oxygen carriers in cardiac care. This work exemplifies their commitment to advancing healthcare through rigorous scientific investigation, bridging clinical applications with cutting-edge research in pharmacology and toxicology. 🔬

Awards and Honors

This individual has received numerous accolades for their contributions to medical research and education, including several funded research grants as Principal Investigator. Their recognition underscores their role as a leader in the field and their dedication to improving health outcomes through science and education. 🏆

Publication Top Notes

“Organ Preservation Solution: A Multidisciplinary Approach” – Journal of Clinical Pharmacology (2023) Cited by 30 articles

“Therapeutic Effectiveness of OxyVita Hemoglobin Based Oxygen Carrier” – Cardiology Research (2022) Cited by 25 articles

“Advancements in Organ Transplantation: A Review” – American Journal of Transplantation (2021) Cited by 40 articles

“Innovative Teaching Methodologies in Medical Education” – Medical Education Online (2020) Cited by 15 articles

 

Min-ran Li | Medicine and Dentistry | Women Researcher Award

Posted on by ScienceFather

Ms. Min-ran Li | Medicine and Dentistry | Women Researcher Award

Ms. Min-ran Li, The First Affiliated Hospital of Jinan University, China

Dr. Minran Li is the Chief Physician at the Division of Infectious Disease at The First Affiliated Hospital of Jinan University. He earned his M.D. in Internal Medicine from Peking University and has extensive expertise in infectious diseases, particularly nonalcoholic steatohepatitis (NASH) and chronic hepatitis B. His research focuses on discovering noninvasive biomarkers and the molecular mechanisms behind liver diseases. Dr. Li has published numerous articles and has been recognized as a Guangdong High-Level Personnel of Young Talents. 🏥📚

Publication Profile

Scopus

 

Education

Ms. Li holds an M.D. in Internal Medicine (Infectious Disease) from Beijing Peking University, a Master’s in Internal Medicine from Hebei Medical University, and a Bachelor’s in Clinical Medicine. This strong educational foundation has empowered her expertise in infectious diseases, particularly liver-related conditions like NASH (nonalcoholic steatohepatitis) and CHB (chronic hepatitis B).

Work Experience

Currently serving as Chief Physician in the Division of Infectious Diseases at the First Affiliated Hospital of Jinan University, Ms. Li has progressively taken on roles of increasing responsibility, including as Associate Chief Physician at The Fifth Hospital of Shijiazhuang. Her work centers on managing liver diseases and exploring innovative biomarkers.

Research Interests

Her research focuses on discovering noninvasive biomarkers for pathological features of NASH in combination with CHB. Her findings on the role of HIGD1A and fibrosis development in liver disease have been pivotal in identifying therapeutic targets, advancing the understanding of liver disease progression.

Awards and Recognitions

Her dedication has been recognized with honors such as the Guangdong High-Level Personnel of Young Talents Program and the Yangcheng Good Doctor Award, underscoring her excellence in medical research and practice.

Conclusion

Ms. Min-ran Li’s strong academic background, leadership in liver disease research, and national and international recognition make her a strong candidate for the Research for Women Researcher Award.

 

Publication Top Notes

  • Pan, Y. et al. (2024). Overexpression of LAG-3: a potential indicator of low immune function in tuberculosis. Frontiers in Cellular and Infection Microbiology, 14, 1410015. 🦠 (0 citations)
  • Li, M.-R. et al. (2024). The function role of HIGD1A in nonalcoholic steatohepatitis from chronic hepatitis B. Scandinavian Journal of Gastroenterology, 59(4), 445–455. 🥗 (0 citations)
  • Li, J.-Z. et al. (2023). Mechanism and Progress of Natural Products in the Treatment of NAFLD-Related Fibrosis. Molecules, 28(23), 7936. 🌿 (0 citations)
  • Li, M.-R. et al. (2023). Clinical Features of Non-Alcoholic Fatty Liver Disease in the Non-Lean Population. Obesity Facts, 16(5), 427–434. 🍔 (1 citation)
  • Pan, Y. et al. (2023). Immune checkpoint inhibitors in cancer patients with COVID-19. Open Life Sciences, 18(1), 20220641. 💉 (1 citation)
  • Li, J.-Z. et al. (2022). Characteristics and treatment strategies for hepatocellular carcinoma caused by nonalcoholic fatty liver disease. Zhonghua gan zang bing za zhi, 30(12), 1392–1396. 🏥 (0 citations)
  • Yang, L. et al. (2022). Progress in research of lipogenesis inhibitors for treatment of nonalcoholic fatty liver disease. World Chinese Journal of Digestology, 30(16), 735–742. 🧬 (1 citation)
  • Li, J.-Z. et al. (2021). The identify role and molecular mechanism of the MALAT1/hsa-mir-20b-5p/TXNIP axis in liver inflammation caused by CHB in patients with chronic HBV infection complicated with NAFLD. Virus Research, 298, 198405. 🔬 (20 citations)
  • Zheng, X.-L. et al. (2021). Effect of optimizing oxygen therapy on multiple organ function and prognosis of patients with COVID-19. Chinese Journal of Pathophysiology, 37(5), 909–914. 🫁 (0 citations)
  • Li, M.-R. et al. (2020). Clinical features of hepatitis B patients at immune-tolerance phase with basal core promoter and/or precore mutations. Journal of Viral Hepatitis, 27(10), 1044–1051. 🦠 (4 citations)

 

 

 

 

Kumiko Kishmoto | Nursing | Best Researcher Award

Posted on by ScienceFather

Dr. Kumiko Kishmoto | Nursing | Best Researcher Award

Dr. Kumiko Kishmoto, Teikyo Heisei University, Japan

Dr. Kumiko Kishimoto has a rich background as a hospital nurse and nursing faculty member. Her current research focuses on the relationship between nurses’ self-compassion and personal factors, as well as the role of psychological safety in psychiatric wards. Committed to enhancing the well-being of nursing professionals, Dr. Kishimoto is dedicated to improving patient care outcomes.

Publication profile

Orcid


Academic and Professional Background

Dr. Kumiko Kishimoto has over 20 years of professional experience in the nursing field, combining a decade of hands-on clinical practice as a hospital nurse with ten years of dedicated service as a nursing faculty member. Her extensive background equips her with valuable insights into both the practical and theoretical aspects of nursing education, fostering a comprehensive understanding of healthcare dynamics. Dr. Kishimoto’s commitment to excellence in nursing is evident in her teaching methodologies, research initiatives, and contributions to the academic community.

Research and Innovations

Dr. Kishimoto’s current research focuses on exploring the relationship between nurses’ self-compassion and various personal factors, emphasizing the significance of psychological safety within psychiatric wards. By investigating these critical dimensions, her work aims to enhance the well-being of nursing professionals and improve patient care outcomes. Her innovative approach addresses vital issues in the nursing profession, advocating for a supportive work environment that promotes mental health and resilience among nurses.

Publication Top Notes

  • The relationships among factors affecting compassion fatigue, compassion satisfaction, and burnout in Japanese nurses: A cross‐sectional study (2024) 🏥
  • The development of the Japanese version of the Forms of Self-Criticising/Attacking & Self-Reassuring Scale (J-FSCRS) (2024) 🧠
  • The development of the Japanese version of the full and short form of Attitudes Towards Mental Health Problems Scale (J-(S) ATMHPS) (2023) 🌍


Conclusion

Dr. Kumiko Kishimoto is a highly qualified candidate for the Best Researcher Award, with a distinguished academic and professional background in nursing. Her innovative research on self-compassion and psychological safety in nursing not only contributes to the field but also has the potential to impact nursing practices positively. Her dedication to improving the mental health and resilience of nurses makes her an exemplary choice for this prestigious recognition.

 

 

James Melrose | Health Professions | Best Researcher Award

Posted on by ScienceFather

Prof. James Melrose | Health Professions | Best Researcher Award

Prof. James Melrose, The University of Sydney, Australia

Based on the provided information, Prof. James Melrose appears to be a highly suitable candidate for the Research for Best Researcher Award. Here’s an evaluation of his qualifications:

Publication profile

Academic and Research Excellence

Prof. Melrose has a solid educational background with a B.Sc (Hons) in Biochemistry and a Ph.D. focused on carbohydrate metabolizing enzymes associated with barley. His long-standing affiliation with prestigious institutions such as The University of Sydney and the University of New South Wales highlights his strong academic and research credentials. Over a period of three decades, he has contributed significantly to bone and joint research, particularly in biochemical and immunological studies.

Special Awards and Recognitions

Prof. Melrose has received numerous prestigious awards throughout his career, demonstrating his recognition by the scientific community. Notable awards include the Smith and Nephew Award for his work on the spine, the Matrix Biology Society’s best poster award, and the European Spine Society’s GRAMMER Award. These accolades emphasize his contributions to the field of spine research and matrix biology, marking him as a leading researcher.

Teaching and Mentorship

Prof. Melrose has a strong background in teaching and mentorship, having served as a laboratory demonstrator, lecturer, and co-supervisor of Ph.D. students. His involvement in training and supervising research personnel at the Raymond Purves Bone and Joint Research Laboratories underscores his commitment to education and nurturing the next generation of researchers. This combination of research and teaching excellence enhances his candidacy for the award.

Publication Top Notes

  • 📚 “Are animal models useful for studying human disc disorders/degeneration?”
    • European Spine Journal 17, 2-19
    • Cited by: 854
    • Year: 2008
  • 📘 “Diverse cell signaling events modulated by perlecan”
    • Biochemistry 47 (43), 11174-11183
    • Cited by: 319
    • Year: 2008
  • 🔬 “Increased nerve and blood vessel ingrowth associated with proteoglycan depletion in an ovine anular lesion model of experimental disc degeneration”
    • Spine 27 (12), 1278-1285
    • Cited by: 255
    • Year: 2002
  • 🧬 “Proteoglycan degradation by the ADAMTS family of proteinases”
    • Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1812 (12)
    • Cited by: 249
    • Year: 2011
  • 🔍 “Keratan sulfate, a complex glycosaminoglycan with unique functional capability”
    • Glycobiology 28 (4), 182-206
    • Cited by: 226
    • Year: 2018
  • 🦴 “Proteoglycan 4 downregulation in a sheep meniscectomy model of early osteoarthritis”
    • Arthritis research & therapy 8, 1-6
    • Cited by: 200
    • Year: 2006
  • 💉 “Not all perlecans are created equal: interactions with fibroblast growth factor (FGF) 2 and FGF receptors”
    • Journal of Biological Chemistry 277 (17), 14657-14665
    • Cited by: 200
    • Year: 2002
  • 🔗 “A comparative analysis of the differential spatial and temporal distributions of the large (aggrecan, versican) and small (decorin, biglycan, fibromodulin) proteoglycans of the…”
    • The Journal of Anatomy 198 (1), 3-15
    • Cited by: 194
    • Year: 2001
  • 🧠 “Increased synthesis of matrix metalloproteinases by aortic smooth muscle cells is implicated in the etiopathogenesis of abdominal aortic aneurysms”
    • Journal of vascular surgery 24 (1), 82-92
    • Cited by: 173
    • Year: 1996
  • 📈 “Comparative spatial and temporal localisation of perlecan, aggrecan and type I, II and IV collagen in the ovine meniscus: an ageing study”
    • Histochemistry and cell biology 124, 225-235
    • Cited by: 164
    • Year: 2005

Conclusion

Prof. James Melrose’s extensive research experience, numerous awards, and significant contributions to biochemistry and spine research make him a highly deserving candidate for the Research for Best Researcher Award. His roles in teaching and mentoring further solidify his position as a leader in his field, making a lasting impact on both research and education.

Amsalu Defersha | Clinical Pharmacy Award | Best Researcher Award

Posted on by ScienceFather

Dr. Amsalu Defersha | Clinical Pharmacy Award | Best Researcher Award

Dr. Amsalu Defersha, United States International University-Africa, Kenya

Dr. Amsalu Defersha, a renowned Clinical Pharmacist and Lecturer, holds a PhD in Clinical Pharmacy from the University of Nairobi. With extensive experience spanning academia and practice, he has taught at prestigious institutions like Ambo University and University of Gondar. A registered Pharmacist in Kenya and Ethiopia, Dr. Defersha’s expertise lies in Pharmacology and Clinical Pharmacy. He’s received notable awards, including scholarships from the European Union and Addis Ababa University. A prolific researcher, he’s secured grants for studies on cancer treatment outcomes. Dr. Defersha’s publications contribute significantly to the field, enhancing patient care and medication management. 🎓💊📚

 

Publication Profile

Orcid

Google Scholar

🎓 Academic Background

Dr. Amsalu Defersha boasts a rich academic journey, culminating in a PhD in Clinical Pharmacy from the University of Nairobi. Prior to this, he earned a Master of Science in Pharmacology from Addis Ababa University and a Master of Pharmacy in Clinical Pharmacy from the University of Nairobi. His educational foundation began with a Bachelor of Pharmacy from Jimma University, Ethiopia.

🏆 Awards and Recognition:

Dr. Defersha’s academic prowess has been recognized with prestigious awards, including the Intra ACP AFIMEGQ Scholarship from the European Union for his Master of Pharmacy studies in Clinical Pharmacy at the University of Nairobi. Additionally, he received a scholarship for his Master of Science studies in Pharmacology from Addis Ababa University.

🔬 Research Grants

Dr. Defersha has secured notable grants for impactful studies. His 2018 research grant from the United States International University-Africa funded a study on treatment outcomes among adult patients with solid malignancies at Kenyatta National Hospital. In 2022, he received another grant to evaluate drug-related problems and treatment outcomes among patients with gastrointestinal cancers

🔍 Research Focus

Dr. Amsalu Defersha’s research primarily centers around pharmaceutical care and clinical outcomes, particularly in the context of chronic diseases such as diabetes, cancer, and cardiovascular disorders. His work delves into medication adherence, drug therapy problems, and treatment outcomes among ambulatory and hospitalized patients. Through systematic reviews, he also explores healthcare provider knowledge and practices, especially during public health crises like the COVID-19 pandemic. With a focus on improving patient care and medication management, Dr. Defersha’s research contributes significantly to enhancing healthcare delivery and optimizing therapeutic interventions. 📊💊🔬

 

Publication Top Notes 

📚Nonadherence and contributing factors among ambulatory patients with antidiabetic medications in Adama Referral Hospital – Published in Journal of Diabetes Research, 2014 – Cited by 102 times

📚 Evaluation of the anti-diarrheal activity of the leaf extract of Croton macrostachyus Hocsht. ex Del. (Euphorbiaceae) in mice model– Published in BMC Complementary and Alternative Medicine, 2016 – Cited by 80 times

📚 Assessment of drug therapy problems among patients with cervical cancer at Kenyatta National Hospital, Kenya, 2017 – Cited by 37 times

📚 Level of adherence to the dietary recommendation and glycemic control among patients with type 2 diabetes mellitus in Eastern Ethiopia: a cross-sectional study– Published in Diabetes, Metabolic Syndrome and Obesity, 2020 – Cited by 31 times

📚Factors affecting health-related quality of life among prostate cancer patients: a systematic review, 2020 – Cited by 27 times

Surgical site infections and prophylaxis antibiotic use in the surgical ward of public hospital in Western Ethiopia: a hospital-based retrospective cross-sectional study

Medication‐related problems and adverse drug reactions in Ethiopia: A systematic review

Prevalence and risk factors of thromboembolism among patients with coronavirus disease-19: a systematic review and meta-analysis

Knowledge, attitude, and practice of healthcare providers toward novel coronavirus 19 during the first months of the pandemic: a systematic review

Evaluation of the antidiarrheal activity of hydromethanol crude extracts of Ruta chalepensis and Vernonia amygdalina in mice